Pangea Pharmaceuticals Announces U.S. Launch of Sdamlo™, the First and Only FDA-Approved, Amlodipine Powder for Oral Solution

Sdamlo, by Pangea Pharmaceuticals, is an FDA-approved amlodipine, unit-dose, alcohol-free solution for pediatric, geriatric, ...

Pangea Pharmaceuticals Announces U.S. Launch of Sdamlo(TM), the First and Only FDA-Approved, Amlodipine Powder for Oral Solution

Pangea Pharmaceuticals, a U.S.-based, patient-centered pharmaceutical company focused on bringing differentiated, clinically relevant products to market, today announced the U.S.
FierceBiotech

Fierce Biotech Layoff Tracker 2026: Replimune reduces staff; Lipella, IO shutter

Welcome to Fierce Biotech’s fifth annual layoff tracker, a resource designed to keep pace with the sector’s steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...